市场调查报告书
商品编码
1403401
到 2030 年医疗保健领域的认知功能评估和培训市场预测:按组件、评估、应用、最终用户和地区进行的全球分析Cognitive Assessment & Training In Healthcare Market Forecasts to 2030 - Global Analysis By Component (Solutions & Services), Assessment (Pen & Paper Based Assessment, Hosted Assessment & Biometrics Assessment), Application, End User & By Geography |
根据 Stratistics MRC 的数据,2023 年全球医疗保健认知评估和培训市场规模为 34.2 亿美元,预测期内复合年增长率为 25.6%,预计到 2030 年将达到 266.7 亿美元。
认知评估和培训透过评估和增强认知功能在医疗保健中发挥重要作用。这些工具可帮助临床医生识别和解决认知功能障碍,并深入了解患者的心理健康状况。将这些工具纳入医疗保健将有助于及早发现认知能力下降并实现个体化介入。
据老年痴呆症协会称,到 2050 年,预计将有超过 1.53 亿人患上失智症,而 2019 年这一数字为 5700 万。
人口老化加剧
随着人口老化的扩大,对有效认知健康解决方案的需求不断增加。因此,医疗保健产业正在关注创新的评估和培训计划,以解决与老龄化相关的认知能力下降、失智症和其他神经退化性疾病。市场正在见证技术进步和个体化方法的激增,以满足老龄化人口的特定认知需求,推动认知医疗解决方案的整体成长和开拓。
资料隐私和安全问题
敏感的患者资讯越来越多地被数位化以用于评估目的,未授权存取和资料外洩的风险构成了重大威胁。问题包括未授权存取个人健康资讯、可能侵犯患者机密以及需要强大的加密措施。由于此类评估通常涉及先进技术,因此确保遵守 HIPAA 等资料保护条例对于保护病患隐私和维持对医疗保健生态系统的信任至关重要。
与电子健康记录 (EHR) 集成
认知健康资料和 EHR 之间的无缝连接可简化患者照护、提高诊断准确性并促进个体化介入。这种整合使医疗保健提供者能够利用全面的患者檔案,促进认知健康的整体方法。随着对认知健康解决方案的需求增加,与 EHR 系统合作将实现一个有凝聚力和高效的医疗保健生态系统,最终将改善患者的治疗结果并扩大认知医疗保健领域。
初期成本高
认知解决方案需要大量的财务投资来实施,这阻碍了普及。创建准确的、经过临床检验的评估,以及製定有效的培训计划,需要大量的研发投资。实施安全资料储存也会增加初期成本。这项挑战可能会阻碍先进认知技术的整合,并限制对创新评估和培训工具的取得。
COVID-19 大流行对医疗保健产生了多方面的影响。它对医疗保健领域的认知评估和培训市场产生了重大影响,增加了对远距解决方案的关注。锁门和社交距离措施加速了认知评估和培训虚拟平台的采用,以满足家庭医疗保健需求。该行业对数位认知健康工具的需求激增,重塑了市场形势。
笔和纸评估部分预计将在预测期内成为最大的部分
基于笔和纸的评估领域预计将经历良好的成长。基于笔和纸的评估在医疗保健市场的认知评估和培训领域仍然很普及。儘管技术不断进步,这些传统方法仍提供了具有成本效益且广泛可用的认知功能评估方法。它继续在认知衰退的基线评估和监测中发挥重要作用。提高认知评估的准确性和效率,同时适应不断变化的医疗保健趋势。
预计临床试验领域在预测期内的复合年增长率最高。
预计临床试验领域在预测期内将出现最高的复合年增长率。这些临床试验的重点是评估和改善心理过程,例如记忆力、注意力和解决问题的能力。在医疗保健市场,我们致力于开发阿兹海默症和认知障碍等疾病的有效干预措施。认知医疗保健的进步继续受益于该领域的持续研究和创新。
由于人口老化加剧、认知健康意识不断提高以及技术进步,预计亚太地区将在预测期内占据最大的市场占有率。该地区的主要企业包括 Cambridge Cognition Ltd.、CogniFit Inc.、Cogstate Ltd. 和 Brain Resource Company。这些公司正在迅速扩大其医疗保健基础设施。政府对医疗保健基础设施的关注和数位医疗解决方案的采用进一步推动了市场的发展。
由于越来越多地采用创新技术进行认知评估和增强,预计北美在预测期内将经历最高的复合年增长率。该市场专注于解决神经系统疾病和促进心理健康,并迅速看到了对个体化、技术主导的解决方案的需求。该地区的主要企业积极与医疗保健提供者合作,提供先进的认知评估工具和培训计划,帮助改善患者的整体治疗效果并推进神经认知医疗保健实践。做出贡献。
According to Stratistics MRC, the Global Cognitive Assessment & Training in Healthcare Market is accounted for $3.42 billion in 2023 and is expected to reach $26.67 billion by 2030 growing at a CAGR of 25.6% during the forecast period. Cognitive assessment and training play crucial roles in healthcare, evaluating and enhancing cognitive functions. These tools help clinicians identify and address cognitive impairments, providing insights into patients' mental health. Integrating these tools into healthcare facilitates early detection of cognitive decline and enables personalized interventions, contributing to more effective patient care and management of conditions like dementia and other cognitive disorders.
According to Alzheimer's Association, more than 153 million individuals will develop dementia by 2050, up from 57 million in 2019.
As the elderly demographic expands, there is a growing demand for effective cognitive health solutions. This has prompted the healthcare industry to focus on innovative assessments and training programs to address age-related cognitive decline, dementia, and other neurodegenerative disorders. The market is witnessing an upsurge in technological advancements and personalized approaches to cater to the specific cognitive needs of the aging population, driving the overall growth and development of cognitive healthcare solutions.
Sensitive patient information is increasingly digitized for assessments, the risk of unauthorized access and data breaches poses a substantial threat. Issues include unauthorized access to personal health information, potential breaches compromising patient confidentiality, and the need for robust encryption measures. As these assessments often involve advanced technologies, ensuring compliance with data protection regulations, such as HIPAA, becomes crucial to safeguarding patient privacy and maintaining trust in the healthcare ecosystem.
Seamless connectivity between cognitive health data and EHR streamlines patient care, enhances diagnostic accuracy, and facilitates personalized interventions. This integration enables healthcare providers to leverage comprehensive patient profiles, fostering a holistic approach to cognitive well-being. As the demand for cognitive health solutions grows, aligning with EHR systems ensures a cohesive and efficient healthcare ecosystem, ultimately improving patient outcomes and advancing the field of cognitive healthcare.
Implementing cognitive solutions requires substantial financial investment, hindering widespread adoption among healthcare providers. The creation of accurate and clinically validated assessments, along with the development of effective training programs, demands substantial research and development investments. Also, implementing secure data storage further contributes to the initial expenses. This challenge may impede the integration of advanced cognitive technologies, limiting access to innovative assessment and training tools.
The COVID-19 pandemic has had multifaceted effects on healthcare. It significantly impacted the Cognitive Assessment and Training in Healthcare Market, with increased focus on remote solutions. Lockdowns and social distancing measures accelerated the adoption of virtual platforms for cognitive assessments and training, addressing the need for at-home healthcare. The industry witnessed a surge in demand for digital cognitive health tools, reshaping the market landscape.
The pen & paper based assessment segment is estimated to have a lucrative growth. Pen and paper-based assessments remain prevalent in the Cognitive Assessment and Training sector within the Healthcare market. Despite technological advancements, these traditional methods offer a cost-effective and widely accessible means of evaluating cognitive functions. They continue to play a crucial role in baseline assessments and monitoring cognitive decline. It enhances accuracy and efficiency in cognitive evaluations while adapting to evolving healthcare trends.
The clinical trials segment is anticipated to witness the highest CAGR growth during the forecast period. These trials focus on assessing and improving mental processes such as memory, attention, and problem-solving. In the healthcare market, they contribute to the development of effective interventions for conditions like Alzheimer's and cognitive impairments. The evolving landscape of cognitive healthcare continues to benefit from ongoing research and innovation in this field.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing aging population, rising awareness of cognitive health, and technological advancements. The region is home for key players such as Cambridge Cognition Ltd., CogniFit Inc., Cogstate Ltd. and Brain Resource Company. These companies are rapidly expanding their healthcare infrastructure. Government's focus on healthcare infrastructure and the adoption of digital health solutions further drive the market.
North America is projected to have the highest CAGR over the forecast period, owing to increasing adoption of innovative technologies for cognitive evaluation and enhancement. With a focus on addressing neurological disorders and promoting mental well-being, the market has witnessed a surge in demand for personalized, technology-driven solutions. Key players in the region are actively collaborating with healthcare providers to deliver advanced cognitive assessment tools and training programs, contributing to the overall improvement of patient outcomes and the advancement of neurocognitive healthcare practices.
Some of the key players profiled in the Cognitive Assessment & Training in Healthcare Market include Cambridge Cognition Ltd, CogniFit Inc, Cogstate Ltd, Eisai Limited, Brain Resource Company, WIRB-Copernicus Group, MedAvante Inc, Quest Diagnostics Incorporated, ProPhase LLC, Signant Health, Linus Health, Posit Science, Clario, Cognetivity Neurosciences, Pear Therapeutics, Akili Interactive Labs and CNS Vital Signs LLC.
In May 2023, Linus Health, a digital health solution provider, announced the result of its digital cognitive assessment solution study with a commonly used, paper-based cognitive test, the Mini-Mental State Examination (MMSE), in detecting cognitive cases of impairment. This solution helps in the earlier identification of cognitive issues.
In January 2022, Eisai Limited announced the launch of CogMate by its Taiwanese and Hong Kong subsidiaries. CogMate is a digital tool for self-assessment of brain health and is expected to be launched in other countries including Singapore.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.